GRCL

Gracell Biotechnologies Inc. (GRCL) | Rumor.io

Gracell Biotechnologies

GRCL

Attention (50-day avg)0%

Attention rank (50-day avg)—

Bullish sentiment (50-day avg)—

Price to earnings ratio0

Market capitalization0

Earnings per share0

Dividend yield (TTM)—

Revenue (annual)0

Net income (annual)0

Social

What share of all stock conversation is about GRCL?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% new	0% new	0% new	0% new

Dec 28

Gracell Biotechnologies Inc. (GRCL) is a Chinese biotech firm that was acquired by Astra Zeneca, considered a momentous event by BTIG.
This is the first time a multinational has taken over a Chinese biotech firm.
The acquisition was considered significant by BTIG.

Generated by AI

Sentiment

Of the messages about GRCL that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	0%
Bearish	—	—	—	100%

Bullish· Dec 26

Gracell Biotechnologies Inc. ($GRCL) is expected to rally to $90 after being acquired by AstraZeneca for a solid premium.
The acquisition of $GRCL by AstraZeneca for $1.2B is a bullish sign, with some analysts predicting a price jump to $11.00+ based on market capitalization adjustments.
Insider buying and the CEO's recent purchase of 1,700,000 shares of $GRCL stock suggest a strong confidence in the company's future prospects.

Bearish· Nov 23

The company's short sellers may be severely impacted, with one post stating that they are "screwed".
The stock's price movement may be driven by speculation and hype, with one post suggesting that it is a "pump and dump" scheme.
The company's recent decline in value may be a sign of underlying weakness, with one post stating that the stock has "eaten my 35% portfolio today".

Generated by AI

Topics

Of the messages about GRCL that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Technical Analysis	0%	0%	0%	0%
Macro	0%	0%	0%	0%
Earnings	0%	0%	0%	0%
Controversies	0%	0%	0%	0%
Announcements	100%	100%	100%	100%
Analysts	0%	0%	0%	0%

Dec 28

Gracell Biotechnologies Inc. was acquired by Astra Zeneca in a momentous deal, as it marks the first time a multinational has taken over a Chinese biotech firm.
BTIG considered the acquisition to be a significant event.
The acquisition highlights Astra Zeneca's expansion into the Chinese biotech market.

Generated by AI

Community

Of the messages about GRCL, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	100%	100%	100%	73.91%
Newcomers	0%	0%	0%	26.09%

Regulars· Jun 14

GRCL has seen significant price appreciation, rising 233.52% in the last quarter and currently trading at $6.6176.
BTIG Research has increased GRCL's price target to $20.00, suggesting a strong future outlook for the company.
GRCL's upcoming US trials in RRMM are expected to be pivotal, particularly with the company's orphan status and the potential for long-term follow-up data to inform future results.

Newcomers· Feb 3

The newcomer is focused on the FDA clearance of the IND application for Phase 1b/2 clinical trial of FasTCAR-T GC012F for the treatment of relapsed/refractory multiple myeloma, and how it affects the stock price.
The newcomer is interested in the potential of Gracell Biotechnologies to help kick cancer's ass and is excited about the company's efforts to develop a treatment for relapsed/refractory multiple myeloma.
The newcomer is tracking the stock's movement and is waiting for a potential entry point, taking into account the strong volume and the key support level at $2.75.

Generated by AI

Also Discussed

Investors talking about GRCL also mention

#	Name	Attention
1	AlloVir, Inc.ALVR	0%0
2	Nkarta, Inc.NKTX	0%0
3	LABP - Landos Biopharma, Inc.	——
4	MOXC - Moxian (BVI) Inc	——
5	HARP - Harpoon Therapeutics, Inc.	——
6	AIH - Aesthetic Medical International Holdings Group Limited	——
7	Longeveron Inc. Class A Common StockLGVN	0%0
8	PLIN - China Xiangtai Food Co., Ltd.	——
9	TEDU - TCTM Kids IT Education Inc.	——
10	Prothena Corp PLCPRTA	0%0